Skip to main content

Marex Group plc

Source: SEC Form 13F · as of Mar 2026

Marex Group plc holds 40 biotech & pharma companies tracked by BioSniper, totaling $53.9M in value as of Mar 2026 (SEC Form 13F).

Companies held

40

Total value held

$53.9M

BioSniper AIPage evidence connected

Prepared research question

What matters most for Sana Biotechnology, Inc. (SANA)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
SANASana Biotechnology, Inc.3,999,100$11.5M
TGTXTG THERAPEUTICS, INC.278,343$9.2M
NTLAIntellia Therapeutics, Inc.623,600$8.0M
DNLIDenali Therapeutics Inc.287,000$5.5M
MRNAModerna, Inc.63,622$3.2M
REGNREGENERON PHARMACEUTICALS, INC.1,739$1.3M
QUREuniQure N.V.80,013$1.3M
VKTXViking Therapeutics, Inc.32,311$1.1M
GILDGILEAD SCIENCES, INC.6,821$951K
RGCRegencell Bioscience Holdings Ltd31,600$804K
AUTLAutolus Therapeutics plc542,857$749K
CYTKCYTOKINETICS INC11,301$745K
TEVATeva Pharmaceutical Industries Limited22,529$679K
ALNYALNYLAM PHARMACEUTICALS, INC.2,000$662K
PTCTPTC THERAPEUTICS, INC.9,334$636K
ARGXARGENX SE858$627K
PCVXVaxcyte, Inc.9,606$558K
TVTXTravere Therapeutics, Inc.18,227$542K
BCYCBICYCLE THERAPEUTICS PLC115,000$534K
BHVNBiohaven Ltd.50,250$425K
KALVKalVista Pharmaceuticals, Inc.20,000$403K
IMVTImmunovant, Inc.16,000$397K
CLDXCelldex Therapeutics, Inc.12,000$381K
DFTXDefinium Therapeutics Inc.20,000$378K
LRMRLarimar Therapeutics, Inc.82,000$369K
BBIOBridgeBio Pharma, Inc.4,860$361K
INSMINSMED Inc2,010$329K
RYTMRHYTHM PHARMACEUTICALS, INC.3,288$286K
IONSIONIS PHARMACEUTICALS INC3,610$271K
RCKTRocket Pharmaceuticals Inc.72,500$260K
APLSApellis Pharmaceuticals, Inc.5,919$238K
ARWRARROWHEAD PHARMACEUTICALS, INC.3,714$233K
FOLDAMICUS THERAPEUTICS, INC.12,418$180K
BMEABiomea Fusion, Inc.100,000$153K
VYGRVoyager Therapeutics, Inc.38,322$148K
LENZLENZ Therapeutics, Inc.16,000$146K
RXRXRECURSION PHARMACEUTICALS, INC.32,788$101K
QNTMQuantum Biopharma Ltd.13,468$65K
SLSSELLAS Life Sciences Group, Inc.10,833$46K
FLNAFilana Therapeutics Inc.10,500$18K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.